pancreatic biopsy
Showing 1 - 25 of 8,755
Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic
Enrolling by invitation
- Pancreatic
-
Shanghai, Shanghai, ChinaXinhua Hospital, Affiliated to Shanghai Jiao Tong University, Sc
Oct 25, 2023
Pancreatic Disease Trial in Fuzhou (Contrast-enhanced ultrasound-guided core biopsy, Conventional ultrasound-guided core biopsy)
Not yet recruiting
- Pancreatic Disease
- Contrast-enhanced ultrasound-guided core biopsy
- Conventional ultrasound-guided core biopsy
-
Fuzhou, Fujian, ChinaFujian Provincial Hospital
Feb 15, 2023
Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses
Completed
- Pancreatic Adenocarcinoma
- +2 more
- endoscopic ultrasound-guided fine needle biopsy
-
Bologna, ItalyGastrointestinal Unit, University of Bologna/Hospital of Imola
Nov 7, 2022
Pancreatic Diseases Trial in Shanghai (Red cell lysis buffer (RCLB) application, Conventional processing)
Not yet recruiting
- Pancreatic Diseases
- Red cell lysis buffer (RCLB) application
- Conventional processing
-
Shanghai, Shanghai, ChinaChanghai Hospital
Jul 12, 2023
Clinical Staging of Chronic Pancreatitis Based on Histopathology
Not yet recruiting
- Chronic Pancreatitis
- pancreatic duct biopsy
-
Shanghai, ChinaChanghai Hospital
Jul 11, 2022
LIver, Biliary tRAct and pancReatic Cancers
Recruiting
- Liver Cancer
- +2 more
- Blood drawing
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, Zhejiang University School of Me
Nov 14, 2023
Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
Active, not recruiting
- Pancreas Adenocarcinoma
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
Sep 27, 2022
Pancreatic Cancer, Gastric Cancer Trial in Hangzhou (Biopsy of tumor tissue for organoid culture)
Recruiting
- Pancreatic Cancer
- Gastric Cancer
- Biopsy of tumor tissue for organoid culture
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of med
Apr 22, 2023
Pancreas Adenocarcinoma Trial in Suwon (Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts
Recruiting
- Pancreas Adenocarcinoma
- Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts establishment group
-
Suwon, Gyeong Gi Do, Korea, Republic ofAjou University Hospital
Oct 7, 2022
Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)
Not yet recruiting
- Non-Small-Cell Lung Carcinoma
- +2 more
- Liquid biopsy
- (no location specified)
Jan 24, 2023
Pancreatic Cancer Trial in Milan (Fine Needle Biopsy or Aspiration)
Recruiting
- Pancreatic Cancer
- Fine Needle Biopsy or Aspiration
-
Milan, ItalyIRCCS San Raffaele Hospital
Jul 17, 2022
Pancreatic Ductal Adenocarcinoma Trial in New Brunswick (Biopsy, Therapeutic Conventional Surgery, Uniformly-labeled
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Biopsy
- +2 more
-
New Brunswick, New Jersey
- +1 more
Oct 17, 2022
A Study of Pancreatic Cancer in Xenografts From Liver Metastases
Completed
- Pancreatic Cancer
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in
Active, not recruiting
- Cancer
-
Shanghai, Shanghai, ChinaRuijin Hospital Affiliated to Shanghai Jiao Tong University Scho
Sep 25, 2022
Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
-
Montpellier, FranceCHU Montpellier
Jul 1, 2022
Liquid biopsY Based cfDNA Methylation and pRotEin biomArKers for
Recruiting
- Cancer
-
Shanghai, Shanghai, ChinaShanghai Changhai Hospital
Aug 9, 2022
PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS Trial (blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor
Not yet recruiting
- PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
- blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor and intracystic fluid samples are taken only if a biopsy is planned following MRI results.
- (no location specified)
Aug 17, 2023
Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8
Recruiting
- Locally Advanced Pancreatic Carcinoma
- +3 more
- Biopsy
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center EDDOP
Nov 30, 2022
Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine
Recruiting
- Pancreatic Carcinoma
- +3 more
-
Beijing, ChinaPeking Union Medical College Hospital
Jan 13, 2022
Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,
Recruiting
- Advanced Fallopian Tube Carcinoma
- +21 more
- Biopsy
- +2 more
-
Bethesda, Maryland
- +2 more
Jan 25, 2023
Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor
Recruiting
- Advanced Lymphoma
- +13 more
- BET Bromodomain Inhibitor ZEN-3694
- +2 more
-
New Haven, ConnecticutYale University Cancer Center LAO
Jun 29, 2022
Pancreatic Cancer Molecular Sub-classification Using Endoscopic
Active, not recruiting
- Pancreas Cancer
-
Rome, ItalyUniversita' Cattolica del Sacro Cuore
Feb 10, 2022
Solid Pancreatic Lesions, EUS-FNB Trial (Wet suction, Dry suction)
Not yet recruiting
- Solid Pancreatic Lesions
- EUS-FNB
- Wet suction
- Dry suction
- (no location specified)
Sep 21, 2022
ful Mutations in Solid Tumor Characterized by Next Generation
Recruiting
- Solid Tumor
- +13 more
-
Aviano, Pordonone, ItalyIRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
Sep 8, 2023
Pancreas Cancer, Pancreas Tumor, Pancreas Adenocarcinoma Trial (Laparoscopic surgical biopsy and organoid generation)
Not yet recruiting
- Pancreas Cancer
- +5 more
- Laparoscopic surgical biopsy and organoid generation
- (no location specified)
Apr 22, 2022